It is essentially a stronger version of Wegovy and Mounjaro, weight-loss medications which are currently available to qualifying patients in the UK
The GLP-1R is expressed on - (glucagon secreting), - (insulin secreting), and - (somatostatin secreting) cells of pancreatic islets, as well as in the heart, lung, kidney, stomach, small intestine, skin, and nerves in the peripheral and central nervous systems (PNS and CNS)
Eligibility requires BMI 30, or BMI 27 with conditions like high blood pressure, sleep apnea, or prediabetesyou'll need recent weight and blood pressure measurements for assessment
It is a measurement for oxidative stress and can help detect diseases in the liver or bile ducts